Painreform Ltd

Company Profile

Painreform Ltd had its IPO on 2020-09-01 under the ticker symbol PRFX.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Painreform Ltd has a staff strength of 6 employees.

Stock update

Shares of Painreform Ltd opened at $4.4 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.21 - $4.6, and closed at $4.48.

This is a +1.59% increase from the previous day's closing price.

A total volume of 34,573 shares were traded at the close of the day’s session.

In the last one week, shares of Painreform Ltd have slipped by -0.44%.

Painreform Ltd's Key Ratios

Painreform Ltd has a market cap of $7.01 million, indicating a price to book ratio of 0.4583 and a price to sales ratio of 0.

In the last 12-months Painreform Ltd’s revenue was $0 with a gross profit of $0 and an EBITDA of $-10001000. The EBITDA ratio measures Painreform Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Painreform Ltd’s operating margin was 0% while its return on assets stood at -51.54% with a return of equity of -88.07%.

In Q2, Painreform Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Painreform Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-17.8 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Painreform Ltd’s profitability.

Painreform Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -2.3394. Its price to sales ratio in the trailing 12-months stood at 0.

Painreform Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$8.32 million

Total Liabilities

$1.10 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Painreform Ltd ended 2024 with $8.32 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.32 million while shareholder equity stood at $6.97 million.

Painreform Ltd ended 2024 with $0 in deferred long-term liabilities, $1.10 million in other current liabilities, 94000.00 in common stock, $-37008000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $5.14 million and cash and short-term investments were $6.15 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Painreform Ltd’s total current assets stands at $8.28 million while long-term investments were $0 and short-term investments were $1.01 million. Its net receivables were $0 compared to accounts payable of $70000.00 and inventory worth $0.

In 2024, Painreform Ltd's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Painreform Ltd paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$4.48

52-Week High

$16.81

52-Week Low

$3.404

Analyst Target Price

$30

Painreform Ltd stock is currently trading at $4.48 per share. It touched a 52-week high of $16.81 and a 52-week low of $16.81. Analysts tracking the stock have a 12-month average target price of $30.

Its 50-day moving average was $6.2 and 200-day moving average was $5.61 The short ratio stood at 0.01 indicating a short percent outstanding of 0%.

Around 555.1% of the company’s stock are held by insiders while 2576.7% are held by institutions.